#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3200	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2558	371.7	0	.	n	.	0	A69G	SNP	69	69	A	541	541	G	442	G,A	278,88	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3200	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2558	371.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1922	1922	T	495	T	419	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3200	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2558	371.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1656	1656	C	489	C,A	389,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5570	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3631	455.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1705	1705	A	458	A	375	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5570	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3631	455.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2339	2339	C	484	C,A	397,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5570	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3631	455.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2413	2413	A	504	A	387	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5570	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3631	455.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2965	2965	C	494	C,A	385,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	486	folP	852	852	99.77	folP.l15.c4.ctg.1	2001	72.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	987	989	AAA	102;103;103	A,C;A;A,C	84,1;83;82,1	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	486	folP	852	852	99.77	folP.l15.c4.ctg.1	2001	72.7	0	.	p	.	0	V275M	NONSYN	823	825	GTG	1359	1361	ATG	111;111;111	A;T;G	86;85;88	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	486	folP	852	852	99.77	folP.l15.c4.ctg.1	2001	72.7	1	SNP	p	R228S	1	.	.	682	684	AGC	1218	1220	AGC	113;113;114	A,C;G;C	88,1;89;91	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1146	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3843	89.0	1	SNP	p	S91F	0	.	.	271	273	TCC	888	890	TCC	84;83;83	T;C;C	70;69;64	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1146	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3843	89.0	1	SNP	p	D95G	0	.	.	283	285	GAC	900	902	GAC	80;79;80	G;A;C	68;65;64	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1146	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3843	89.0	1	SNP	p	D95N	0	.	.	283	285	GAC	900	902	GAC	80;79;80	G;A;C	68;65;64	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	458	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1672	81.7	1	SNP	p	G45D	0	.	.	133	135	GGC	584	586	GGC	147;147;149	G;G;C	123;122;121	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	270	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1411	57.3	0	.	n	.	0	A197.	DEL	197	197	A	774	774	A	123	A	93	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3264	100.3	1	SNP	p	D86N	0	.	.	256	258	GAC	786	788	GAC	126;125;125	G;A;C	101;92;98	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3264	100.3	1	SNP	p	S87R	0	.	.	259	261	AGT	789	791	AGT	124;124;124	A;G;T	93;98;101	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3264	100.3	1	SNP	p	S87I	0	.	.	259	261	AGT	789	791	AGT	124;124;124	A;G;T	93;98;101	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3264	100.3	1	SNP	p	S87W	0	.	.	259	261	AGT	789	791	AGT	124;124;124	A;G;T	93;98;101	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3264	100.3	1	SNP	p	S88P	0	.	.	262	264	TCC	792	794	TCC	124;124;123	T;C;C	99;98;99	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	926	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3087	89.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1738	1740	GGC	134;134;135	G;G;C	108;109;106	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1435	1437	GCA	138;139;138	G,A;C;A,G,C	115,2;116;115,1,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1438	1440	ATC	137;136;137	A;T;C	115;110;110	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1450	1452	GTG	137;135;136	G;T;G	109;107;107	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1450	1452	GTG	137;135;136	G;T;G	109;107;107	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1954	1956	ACC	91;92;93	A;C;C	69;71;73	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2008	2010	GCG	89;89;90	G;C;G	65;60;64	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2008	2010	GCG	89;89;90	G;C;G	65;60;64	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2131	2133	GGC	91;91;89	G;G;C	76;75;74	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2140	2142	GGC	87;87;86	G;G;C	77;76;75	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	854	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2714	94.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2158	2160	CTG	88;89;90	C;T;G	79;78;77	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1122	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3415	98.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1700	1702	CCG	90;90;89	C;C;G	68;68;69	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	490	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2133	68.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	682	682	C	85	C	68	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1181	1183	AAT	9;9;9	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1184	1186	AAT	9;9;9	A;A;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1208	1210	GCA	9;9;9	G;C;A	7;6;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1231	1233	GTA	9;9;9	G;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1237	1239	AAC	9;9;9	A;A;C	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1241	1245	TGGCG	9;9;9;9;9	T;G;G;C;G	6;7;7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1247	1249	GCT	9;9;9	G;C;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1307	1309	TTA	10;10;10	T;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1352	1354	CAT	10;10;10	C;A;T	7;7;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1355	1357	AGT	10;9;9	A;G;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	297	90.37	porB1a.l6.c4.ctg.1	1453	17.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1364	1366	TAC	9;9;9	T;A;C	6;5;6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	706	708	GAA	130;129;128	G;A;A	100;101;102	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	994	996	GAT	124;122;122	G;A;T,A	103;97;95,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1117	1119	TCA	122;122;121	T;C;A,T	97;96;97,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	0	.	p	.	0	K207E	NONSYN	619	621	AAA	1213	1215	GAA	116;116;114	G;A;A,C	97;94;94,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1246	1248	GTC	114;115;115	G;T;C	93;93;96	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1258	1260	TCT	118;119;120	T,G,A;C;T,G,A	92,1,1;96;99,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1576	1578	GCA	114;116;116	G;C;A	90;87;85	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	1	SNP	p	G120K	1	.	.	358	360	AAG	952	954	AAG	125;125;124	A;A;G	98;100;96	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	1	SNP	p	D121N	0	.	.	361	363	GAC	955	957	GAC	123;123;123	G;A,C;C	99;96,1;97	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	580	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	2098	82.3	1	SNP	p	A121D	1	.	.	361	363	GAC	955	957	GAC	123;123;123	G;A,C;C	99;96,1;97	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2418	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5351	135.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2176	2178	AAT	118;118;117	A;A;T	95;96;93	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	316	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1422	66.7	1	SNP	p	V57M	1	.	.	169	171	ATG	713	715	ATG	112;112;111	A;T;G	95;94;94	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
